Genetic Technologies Ltd (NASDAQ:GENE)

5.83
Delayed Data
As of Feb 27
 -0.71 / -10.86%
Today’s Change
1.04
Today|||52-Week Range
11.00
+202.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$23.9M

Company Description

Genetic Technologies Ltd. engages in the business of genetic testing services. The company performs a variety of genetic tests on humans and animals which includes human diagnostics, forensics and animal pedigree tests. It operates its business under three segments: Operations, Licensing and Research. The Operations segment involves the provision of a range of genetic testing services. The Licensing segment involves the out-licensing of its intellectual property relating to """"non-coding DNA"""" technology. The Research segment involves the undertaking of a range of research and development projects in the field of genetics and related areas. The company acquired business, which engages in biotechnology and genetics was founded in 1989. Genetic Technologies was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Contact Information

Genetic Technologies Ltd.
60-66 Hanover Street
Fitzroy Victoria (vic) 3065
P:(138) 412-7000
Investor Relations:

Employees

Shareholders

Other institutional1.29%
Mutual fund holders0.12%
Individual stakeholders--

Top Executives

Eutillio BuccilliChief Executive, Operating & Financial Officer
Richard AllmanScientific Director
Diana NewportDirector-Quality & Business Operations
Bronwyn ChristieSecretary & Controller
Danielle SavaglioSenior Director-Global Human Resources

To view my watchlist

Not a member yet?

Sign up now for a free account